Home/Filings/4/0001827506-25-000009
4//SEC Filing

Johnson Kevin Bruce 4

Accession 0001827506-25-000009

CIK 0001827506other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:22 PM ET

Size

5.6 KB

Accession

0001827506-25-000009

Insider Transaction Report

Form 4
Period: 2025-01-27
Johnson Kevin Bruce
Chief Regulatory Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-01-27+58,00058,000 total
    Exercise: $17.00Exp: 2035-01-26Common Stock (58,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest as to 25% of the shares on January 27, 2026, with the remainder vesting in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Tourmaline Bio, Inc.

CIK 0001827506

Entity typeother

Related Parties

1
  • filerCIK 0001994710

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:22 PM ET
Size
5.6 KB